The application of Oct4 CM, c-Myc CM, and Oct4/c-Myc CM to tumor cells reduced the proliferation, migration, invasion, and growth of three-dimensional tumor spheroids, and in the mouse models, the systemic administration of CMs inhibited the growth of mammary tumors and bone degradation. The gene discussed is MYC; the disease is neoplasm.